Stockscreener 앱 받기
1.40
4.48%
0.06
시간 외 거래:
1.37
-0.03
-2.14%
전일 마감가:
$1.34
열려 있는:
$1.33
하루 거래량:
61,012
Relative Volume:
0.29
시가총액:
$10.03M
수익:
-
순이익/손실:
$-23.36M
주가수익비율:
-1.9001
EPS:
-0.7368
순현금흐름:
-
1주 성능:
-6.04%
1개월 성능:
-9.09%
6개월 성능:
-71.57%
1년 성능:
-94.22%
1일 변동 폭
$1.33
$1.40
1주일 범위
$1.2875
$1.53
52주 변동 폭
$1.10
$27.63
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
명칭
Calidi Biotherapeutics Inc
전화
(858) 794-9600
주소
4475 Executive Drive, Suite 200, San Diego
CLDI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
1.40 | 9.60M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-22 | 개시 | H.C. Wainwright | Buy |
| 2023-10-09 | 개시 | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
Calidi Biotherapeutics Inc. (CLDI) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
What margin trends mean for Calidi Biotherapeutics Inc. stockMarket Growth Summary & Daily Chart Pattern Signals - newser.com
Will Calidi Biotherapeutics Inc. stock outperform small cap peersPortfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Will Calidi Biotherapeutics Inc. stock recover faster than industryTrade Exit Report & Weekly High Conviction Trade Ideas - newser.com
Will Calidi Biotherapeutics Inc. stock sustain bullish trend into 2025 - newser.com
Will Calidi Biotherapeutics Inc. stock benefit from commodity pricesAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com
Why Calidi Biotherapeutics Inc. stock stays undervaluedWeekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com
Calidi Biotherapeutics Inc.’s volatility index tracking explainedJuly 2025 Review & Entry Point Confirmation Signals - newser.com
How analysts revise price targets for Calidi Biotherapeutics Inc. stockMarket Growth Review & Growth-Oriented Investment Plans - newser.com
Will Calidi Biotherapeutics Inc. stock split increase liquidityJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Signal strength of Calidi Biotherapeutics Inc. stock in tech scannersJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
What recovery options are there for Calidi Biotherapeutics Inc.Quarterly Profit Summary & High Conviction Buy Zone Picks - newser.com
Analyzing recovery setups for Calidi Biotherapeutics Inc. investors2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Certain Common Stock of Calidi Biotherapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-NOV-2025. - MarketScreener
Certain Options of Calidi Biotherapeutics, Inc. are subject to a Lock-Up Agreement Ending on 19-NOV-2025. - MarketScreener
Calidi Biotherapeutics Unveils New Data on CLD-401 - MSN
Can Calidi Biotherapeutics Inc. stock beat market expectations this quarterWeekly Risk Summary & Proven Capital Preservation Tips - newser.com
Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Commercial Appeal
Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025 - The Manila Times
Calidi Biotherapeutics (CLDI) Details RedTail, $560B Oncology Webinar Nov. 19 - Stock Titan
Is Calidi Biotherapeutics Inc. stock supported by strong cash flowsWeekly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Using data models to predict Calidi Biotherapeutics Inc. stock movementWeekly Profit Report & Proven Capital Preservation Methods - newser.com
Calidi Biotherapeutics Inc (CLDI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
1.88%
자본화:
|
볼륨(24시간):